<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='1952-1223'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/test/">Test</a>
<span>AML Cytogenetics 1 </span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">AML Cytogenetics 1 (Karyotyping + FISH for AML-ETO + Inv(16) + MLL + PML/RARA) </h1>
<div class="post-text">
<p>AML Cytogenetics 1 is an advanced diagnostic testing panel employed to analyze patients who are suspected to have Acute Myeloid Leukemia (AML), a type of cancer that affects the bone marrow and blood. AML Cytogenetics 1 combines karyotyping with Fluorescence In Situ Hybridization (FISH) tests. Karyotyping helps in examining the number and structure of chromosomes in blood or bone marrow cells. The FISH tests are targeted to identify specific chromosomal abnormalities associated with AML, specifically AML-ETO, Inv(16), MLL, and PML/RARA. These genetic alterations are significant in the diagnosis and categorization of AML and have implications for treatment decisions and prognosis</p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Test Name</th>
			<td scope="col">AML Cytogenetics 1 (Karyotyping + FISH for AML-ETO + Inv(16) + MLL + PML/RARA) </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td> Bone Marrow or Blood </td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>No special preparation such as fasting is required for this test. However, it’s vital to inform your doctor about any medications being taken. </td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td> 12 Days for Karyotype & 5 Days for FISH </td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>₹ 15900  </td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
	<h2 class="test-h2 mt-3">What is Acute Myeloid Leukemia (AML)? </h2>
	<p>AML is a form of cancer that begins in the bone marrow and results in rapid production of abnormal myeloblasts, a type of white blood cell. These abnormal cells interfere with the production of normal blood cells. </p>
	<h2 class="test-h2 mt-3">Why is the AML Cytogenetics 1 panel important? </h2>
	<p>This panel is essential for the proper diagnosis and categorization of AML. By detecting specific chromosomal abnormalities, the panel can help identify the subtype of AML, which is crucial for determining prognosis and guiding treatment decisions. </p>
	<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->
	<h2 class="test-h2 mt-3">What information does the AML Cytogenetics 1 panel offer? </h2>
	<p>The panel offers detailed information regarding the chromosomal structure and specific abnormalities such as AML-ETO, Inv(16), MLL, and PML/RARA. This information is crucial for diagnosing AML, identifying its subtype, and understanding its behavior. </p>
	<h2 class="test-h2 mt-3">When should this test be done? </h2>
	<p>This test is usually recommended when there are signs or symptoms indicative of leukemia, such as fatigue, fever, or abnormal blood counts. It’s also used for monitoring the disease during treatment. </p>
	<h2 class="test-h2 mt-3">What are the normal values for this test? </h2>
	<p>Normal results would show no chromosomal abnormalities. However, in AML, specific chromosomal abnormalities can be present, and identifying these is essential for diagnosis and treatment. </p>
	<h2 class="test-h2 mt-3">What factors can affect the results? </h2>
	<p>Genetic mutations, the presence of leukemia cells, and certain medications can affect the test results. It’s important to discuss all medications and supplements you are taking with your doctor. </p>
	<h2 class="test-h2 mt-3">What are the risks associated with this test? </h2>
	<p>The risks are comparable to those of a regular blood draw. If a bone marrow sample is needed, there may be additional risks, such as infection or bleeding at the sample site. </p>
	<h2 class="test-h2 mt-3">How will this test influence treatment decisions? </h2>
	<p>The identification of specific chromosomal abnormalities allows doctors to tailor treatment strategies based on the subtype of AML, which can be more effective in managing the disease. </p>
	<h2 class="test-h2 mt-3">What doctor should I consult if the test results are abnormal? </h2>
	<p>If the test results are abnormal, it is critical to consult a hematologist or an oncologist who specializes in blood cancers. </p>
	<h2 class="test-h2 mt-3">How frequently should this test be performed? </h2>
	<p>This test is usually performed at the time of diagnosis. It may be repeated during treatment to monitor the response to therapy or to check for recurrence. </p>
	<h2 class="test-h2 mt-3">What is the role of FISH in this panel? </h2>
	<p>FISH allows for the detection of specific genetic changes and chromosomal rearrangements that are too small to be seen with karyotyping. It helps in identifying specific subtypes of AML, which can be critical for prognosis and treatment. </p>
	<h2 class="test-h2 mt-3">What is karyotyping? </h2>
	<p>Karyotyping is a test that evaluates the number and structure of chromosomes in cells. In AML, karyotyping is used to find out if there are chromosomal changes that might be causing or advancing the leukemia. </p>
	<h2 class="test-h2 mt-3">Can lifestyle or dietary changes impact the results or management of AML? </h2>
	<p>While lifestyle and dietary changes may contribute to the overall health of a patient with AML, they are unlikely to significantly impact the results of the genetic tests or the course of the disease. <br><br>
Understanding the genetic makeup of Acute Myeloid Leukemia is crucial for ensuring the best possible outcome. The AML Cytogenetics 1 panel is an essential component of the diagnostic process and guides the decision-making for treatment strategies. It is vital to keep in communication with your doctor and actively participate in the management and treatment plan. </p>
	
</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>